Ross Macdonald | Chief Executive Officer
Cynata Therapeutics Ltd

Ross Macdonald, Chief Executive Officer, Cynata Therapeutics Ltd

Dr Ross Macdonald is the CEO of Cynata Therapeutics Limited.  Qualified with both a PhD and a business degree, he has 30 years’ experience and a track record of success in pharmaceutical and biotechnology businesses. Specifically, he has stewarded many medical discoveries through clinical development to eventual global commercial application.

Appearances:



Advanced Therapies and Regenerative Medicine Day 2 - Thursday 17th May 2018 @ 11:40

Clinical development of the world’s first iPSC-derived MSC therapeutic product

Experience gained from conducting the world’s first clinical trial of an allogeneic, iPSC-derived cell therapy product
New, second-generation approach to manufacturing therapeutic MSCs that provides a robust, consistent product without reliance upon multiple donors
Progress toward delivering a successful product for graft-versus-host disease and potentially other targets.

back to speakers

 

TO SPONSOR / EXHIBIT

Erica Baeta
+44 (0)207 092 1152
erica.baeta@terrapinn.com

TO SPEAK

Jessica Robinson
t/ +44 (0)207 092 1150
jessica.robinson@terrapinn.com

TO REGISTER

Issa Mauthoor
+44 (0)207 092 1257
issa.mauthoor@terrapinn.com